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INTRODUCTION: Nanoparticles of many types have been created for industrial and 
medical applications.  Among these nanoparticles, single-walled carbon nanotubes 
(SWCNT) are of high interest for their physicochemical properties and application in 
electronics, drug delivery and other areas.  With the rapid expansion in SWCNT-based 
new technologies, a full understanding of their safety and risks for human exposure 
must be considered.  Because of the potential human risk of nanoparticle exposure we 
have developed an animal model to study the effects of nanoparticle exposure on lung 
tissue. Using this rat model we hypothesized that an acute nanoparticle exposure would 
result in an inflammatory response in lung tissue.   METHODS:  Particle instillation 
(intratracheal under direct visualization) of 50 µL pediatric surfactant containing 500 
micrograms SWCNT (or surfactant alone) was performed in 32 rats to date. Pulmonary 
histology and biochemical measures on bronchoalveolar lavage (BAL), pleural fluid, 
serum and lung cells was quantified.  RESULTS:  Very early (<30 minutes) eosinophilia 
developed in lung tissue following SWCNT instillation. Innate immune system sterile 
response, or Damage Associated Molecular Patterns (DAMPs) protein was released. 
Our dose proved sterile, <0.03 EU LPS, showing the effect was damage-induced not 
pathogen-induced.  High mobility group box protein-1 (HMGB1), a nuclear chaperone 
and prototype DAMP was elevated (ELISA) following SWCNT exposure.  A second 
DAMP, heatshock protein 70 (HSP-70), a cytoplasmic chaperone, was also quantified 
by ELISA.  The response OF HSP-70 over time is similar to HMGB1. Western blots 
performed on time-harvested lungs exposed to SWCNT demonstrated a receptor for 
advanced glycation end products (RAGE), with a strong peak at 3 hours after 
pulmonary exposure. The inflammatory cytokine TNFα appeared in lung tissue and 
bronchial alveolar lavage (BAL) at 30 minutes, with the same timing as the HMGB1 and 
HSP-70 release. Flow cytometry of type II pneumocytes and pulmonary macrophages 
from SWCNT-exposed rats demonstrated secondary DAMP receptors. A potential 
chronic effect was noted at one month.  HMGB1 and HSP-70 peaked acutely at 
approximately 24 hr and then slowly decreased at 1 to 2 weeks.  At 1 month, however, 
a new increase was seen. CONCLUSIONS:  The hydrophobic SWCNT, important 
industrial components, form bundles and fibers in the hydrophilic lung, creating an 
immediate cellular inflammatory response, measurable cellular necrosis and very rapid 
chemokine release.  Early data suggests the potential for chronicity.   
